Eton Pharmaceuticals (ETON) COO discloses options and 128,985 performance RSUs
Rhea-AI Filing Summary
Eton Pharmaceuticals’ Chief Operating Officer Danka Radosavljevic filed an initial statement of beneficial ownership, detailing equity interests in Eton common stock and equity awards. Reported positions include multiple employee stock options with exercise prices ranging from $1.38 to $15.47 per share and expiration dates between 2027 and 2036, time-vested restricted stock units, and a sizeable performance-based award.
The performance-vested restricted stock unit grant covers 128,985 potential shares and vests in full only if Eton’s common stock closing price reaches or exceeds $72.36 for one trading day on or before July 31, 2029; otherwise, it is forfeited. The filing reflects holdings only and does not report any concurrent purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Restricted Stock Units F3, F2 | -- | -- | -- |
| holding | Restricted Stock Units F3, F4 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F6 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F7 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F8 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F10 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F11 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F12 | -- | -- | -- |
| holding | Common Stock F13 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (13)
- F1. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030.
- F2. The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
- F3. Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- F4. The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
- F5. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
- F6. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on March 18, 2029.
- F7. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.
- F8. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on August 15, 2027.
- F9. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2027.
- F10. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2025.
- F11. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on March 12, 2024.
- F12. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on July 24, 2021.
- F13. On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029. The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Key Figures
Key Terms
Restricted Stock Units financial
performance-vested restricted stock units financial
equity incentive plan financial
market condition financial
beneficial ownership financial
FAQ
What does ETON’s Form 3 filing for Danka Radosavljevic show?
How many performance-vested RSUs does ETON’s COO hold under this Form 3?
What market condition applies to the 128,985 performance RSUs reported by ETON?
What stock option grants are disclosed for ETON’s COO in this Form 3?
How do the time-vested RSUs in ETON’s Form 3 vest for the COO?
Does ETON’s Form 3 for Danka Radosavljevic report any stock purchases or sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.